neobookRx
DrugsLevel 4 LocalisationS0GRAEML

Potassium Sodium Hydrogen Citrate

Citrate compoundUrolitholytic, Urinary alkaliniser

Indications

Registered South African indications:

  • Urinary tract calculi
  • Alkalinise the urine

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients
  • Renal impairment
  • Hepatic impairment
  • Cardiac failure
  • Hypernatraemia
  • Hyperkalaemia
  • Alkalosis
  • Coadministration with potassium sparing diuretics

Cautions

  • Pregnancy
  • Breastfeeding
  • Elderly
  • Adrenal insufficiency
  • Sodium controlled diet

Adult dosage

Forms avail. in SA and covered in this monograph: gra

Uric acid caculi
- To dissolve uric acid calculi in the urinary tract and to prevent further stone formation
To alkalinise the urine during treatment with uricosuric agents and during cytostatic therapy

  • Oral (gra): The dose is adjusted according to pH value of the urine; Maintenance: 10g/day
Time
Dose
Morning, as early as possible
2.5g
Midday
2.5g
Evening, as late as possible
5g

The granules should be dissolved, by stirring in half a glass of water or fruit juice and taken, preferably after meals


Check the pH value of the urine before each dose


The pH value shows the response to the previous dose


See additional prescribing points 

Paediatric dosage

No information available

Special populations

Pregnancy

Breastfeeding

Renal Impairment

Hepatic Impairment

Elderly

Drugs in Sport

  • Permitted - No warning

Adverse reactions

Gastrointestinal Disorders

  • Gastric irritation

Endocrine and Metabolic Disorders

  • Metabolic alkalosis

Interactions

  • Ciprofloxacin
  • Norfloxacin 
  • Ofloxacin
  • Salicylates
  • Urinary antiseptics
  • Antacids
  • Potassium sparing diuretics

Monitoring

Urine pH

Prescribing points

Reference pH ranges

Uric acid calculi

  • The pH should be stabilised with within the desired range 6.2-6.8

During treatment uricosuric agents

  • The pH should be stabilised between 6.2-6.8

During cytostatic therapy 

  • The urine pH should be at least 7.0

Directions for use

  • When changing the dose, it is advisable to increase or decrease it in steps of half a spoonful only
  • Measure urine pH with the enclosed indicator strips
  • A test result of 7 or more at midday means that the morning dose was too high. Reduce the next morning dose so that the pH response at next midday will then fall within the correct range. The same applies to other recordings
  • If the morning pH is found to be too low (less than 6), this means that too small a dose of the granules was taken on the previous evening. Therefore, the next evening dose should be increased

Mechanism of action

Potassium sodium hydrogen citrate alkalinises the urine.

Dosage forms

  • Granules

Formulation

Potassium sodium hydrogen citrate is available in several formulations. Please note the list below gives examples of products which are available and is not necessarily comprehensive. The listing of a product does not constitute endorsement of the product by EMGuidance; likewise, failure to list a product does not imply that EMGuidance disapproves of the product. This information is put together on the basis of the National Government's Medicines Price Registry at the time of publication

Granules  

  • Uralyt-U (Takeda)

References

1. SAMF_12th Edition_Page 247 2. https://drive.google.com/drive/folders/0B27NqM_vidrmNDJURnktVWhVMVU (16/05/1995_Takeda_Uralyt-U_gran) *no uptodate *no drugs.com *no spc

Brands & products

0 products · cached snapshot
Trade names (1)
  • Uralyt-U

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Interacts with 3 known drugs

Check against other drugs →
NeoHealth® ID 15731 · updated 7/12/2022